Deviation – Page 27 – Pharma.Tips

Unvalidated aseptic intervention during cleaning verification – patient safety risk case study

Case Study: Risks of Unvalidated Aseptic Intervention During Cleaning Verification In a recent scenario at a pharmaceutical manufacturing facility, an unvalidated aseptic intervention during the cleaning verification process led to…

Gowning deviation ignored during aseptic filling – regulatory enforcement outcome

Investigation of an Aseptic Filling Gowning Deviation Ignored: A Regulatory Perspective The pharma industry operates under stringent regulations to ensure product quality and patient safety. However, deviations can occur, impacting…

Unvalidated aseptic intervention during aseptic filling – patient safety risk case study

Exploring Unvalidated Aseptic Interventions During Aseptic Filling: A Case Study In a recent incident at a large pharmaceutical manufacturing facility, an unvalidated aseptic intervention during aseptic filling raised significant concerns…

Bioburden excursion before filtration during aseptic filling – regulatory enforcement outcome

Managing Bioburden Excursions in Aseptic Filling: A Case Study In the high-stakes environment of pharmaceutical manufacturing, maintaining sterility is paramount. A recent case of bioburden excursion before filtration during aseptic…

Cross-contamination detected post-release during aseptic filling – patient safety risk case study

Case Study on Post-Release Cross-Contamination during Aseptic Filling In a recent incident within a high-volume aseptic filling facility, cross-contamination was detected during a post-release quality control test, sparking significant patient…

Sterility test failure misclassified during aseptic filling – containment CAPA failure

Case Study: Misclassification of Sterility Test Failure During Aseptic Filling and Subsequent CAPA Implementation The misclassification of sterility test failures can have significant regulatory implications for pharmaceutical manufacturers. This case…

Unvalidated aseptic intervention during media fill – containment CAPA failure

Analysis of Unvalidated Aseptic Intervention during Media Fill and Its Implications for CAPA In the highly regulated pharmaceutical industry, maintaining the integrity of aseptic processes is crucial for ensuring product…

Media fill deviation not escalated during investigation – regulatory enforcement outcome

Case Study: Regulatory Consequences of Unresolved Media Fill Deviations In the pharmaceutical manufacturing environment, ensuring sterility and compliance with regulatory expectations is paramount. This case study outlines a real-world scenario…

Contamination source misidentified during media fill – patient safety risk case study

Case Study: Misidentifying Contamination Sources During Media Fill Operations In pharmaceutical manufacturing, maintaining sterility and integrity during media fill operations is critical to ensuring patient safety and compliance with Good…

Unvalidated aseptic intervention during media fill – patient safety risk case study

Case Study on Unvalidated Aseptic Intervention During Media Fill: A Patient Safety Risk In this case study, we will explore a real-world scenario involving an unvalidated aseptic intervention during a…

Unvalidated aseptic intervention during cleaning verification – containment CAPA failure

Managing Unvalidated Aseptic Interventions During Cleaning Verification: A Case Study in CAPA Implementation The pharmaceutical industry faces ongoing challenges with maintaining compliance and ensuring product integrity during manufacturing processes. One…

Media fill deviation not escalated during cleaning verification – patient safety risk case study

Investigation of Media Fill Deviation During Cleaning Verification: A Case Study In the context of pharmaceutical manufacturing, the integrity of the sterility assurance process is paramount. This case study involves…